Figure 2From: Long-term consistent use of a vaginal microbicide gel among HIV-1 sero-discordant couples in a phase III clinical trial (MDP 301) in rural south-west Uganda Proportions of women reporting gel use at the last sex act at each clinical visit during follow-up. Back to article page